Drug Type Small molecule drug |
Synonyms Etiguanfacine (USAN/INN), SSP-1871 |
Target |
Action agonists |
Mechanism α-adrenergic receptor agonists(Alpha adrenergic receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingClinical |
First Approval Date- |
Regulation- |
Molecular FormulaC12H14Cl3N3O3 |
InChIKeyNCLJTNUXXNRGLY-UHFFFAOYSA-N |
CAS Registry1364788-17-9 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| D10629 | - | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Attention Deficit Disorder With Hyperactivity | Clinical | - | - | |
| Hypertension | Clinical | - | - |





